Literature DB >> 3259862

Paced skeletal muscle for dynamic cardiomyoplasty.

G J Magovern1, F R Heckler, S B Park, I Y Christlieb, G A Liebler, J A Burkholder, T D Maher, D H Benckart, G J Magovern1, R L Kao.   

Abstract

Four patients, each with a history of myocardial infarction and diffuse coronary artery disease, underwent application of left latissimus dorsi (LD) muscle with intact neurovascular bundle to the anterolateral wall of the left ventricle. The muscle was conditioned over a six-week period subsequent to operation in 3 patients and was conditioned preoperatively with a burst stimulus in the fourth. Biopsy specimens confirm the experimental data that human skeletal muscle can be electrically conditioned over a six- to ten-week period to contain mainly fatigue-resistant type I fibers. All patients survived the procedure, and 3 showed improvement secondary to aneurysmectomy. In Patient 1, a modified resection was performed, and at 28 months after operation, at the 75-W level of exercise, the ejection fraction was 54% paced versus 45% nonpaced. In Patient 2, at 12 months, the ejection fraction at rest was 44% paced versus 30% nonpaced. Doppler echo studies confirmed the presence of the flap and its function in the paced and nonpaced mode. The third patient died of a sudden ventricular arrhythmia 2 months following operation. An infected, nonfunctioning, degenerated flap was found at autopsy. Patient 4 did not have an aneurysm. She received a bypass graft to the right coronary artery and underwent cardiomyopexy in an attempt to relieve medically refractory incapacitating chronic congestive heart failure. Ten months postoperatively, ejection fraction at rest was 33% paced versus 25% nonpaced. Constrictive myopathy has not been encountered in any of these patients.

Entities:  

Mesh:

Year:  1988        PMID: 3259862     DOI: 10.1016/s0003-4975(10)64761-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

Review 1.  Surgical approaches to dilated cardiomyopathy.

Authors:  I A Smolens; S F Bolling
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.